SEP 01, 2020 3:18 PM PDT

First Novel Compounds to Inhibit Cancer-Linked Enzymes

WRITTEN BY: Nouran Amin

Researchers from the University of Michigan Rogel Cancer Center have worked on creating a therapeutic-based compound that can block the activity of cancer-linked enzymes. The particular family of enzymes examined in the study is known as the nuclear receptor-binding SET domain (NSD). The enzymes are part of a family of histone methyltransferases that have long been studied as an attractive drug target. However, the efforts to attack the activity of these enzymes have been challenging because of the shape of the binding sites where drug-like molecules are supposed to attach.

Learn more about enzymatic activity in cancer:

To develop the first-in-class inhibitors, Tomasz Cierpicki, Ph.D., and Jolanta Grembecka, used multiple approaches including X-ray crystallography and nuclear magnetic resonance. The work has led to the inhibition of a key protein known as NSD1. Specifically, they developed a compound known as ‘BT5’ and was shown promise in leukemic cells.

Findings were published in Nature Chemical Biology.

"Our study, which was years in the making, demonstrates that targeting this key enzyme with small-molecule inhibitors is a feasible approach," says Cierpicki, an associate professor of biophysics and pathology at U-M. "These findings will facilitate the development of the next generation of potent and selective inhibitors of these enzymes, which are overexpressed, mutated or undergo translocations in several types of cancer."

Source: Science Daily

About the Author
  • Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
JAN 20, 2021
Microbiology
Cannabis Compound Could Lead to New Class of Antibiotics
JAN 20, 2021
Cannabis Compound Could Lead to New Class of Antibiotics
For the first time, a synthetic version of a non-psychoactive molecule found in marijuana has been shown to kill pathoge ...
FEB 07, 2021
Drug Discovery & Development
Beta-Blockers Can Repair Broken Blood Vessels
FEB 07, 2021
Beta-Blockers Can Repair Broken Blood Vessels
Propranolol is a drug that can treat infantile haemangiomas but was found to also treat a blood vessel condition that le ...
MAR 01, 2021
Microbiology
New Therapeutic Potential for a 'Miracle Poison'
MAR 01, 2021
New Therapeutic Potential for a 'Miracle Poison'
Most people know botulism as a nasty disease and botox as a wrinkle reducer that may cause a 'frozen' look if it's overu ...
MAR 09, 2021
Cannabis Sciences
Cannabis Alleviates Neuropathic Pain from Chemotherapy
MAR 09, 2021
Cannabis Alleviates Neuropathic Pain from Chemotherapy
Neuropathic pain from oxaliplatin-based chemotherapy regimens occurs in up to 90% of patients, and continued exposure to ...
APR 01, 2021
Microbiology
Mapping the Wild Microbiome to Search for Therapeutic Agents
APR 01, 2021
Mapping the Wild Microbiome to Search for Therapeutic Agents
Many people think of bacteria as disgusting germs, but there are plenty of important bacterial species that provide us w ...
MAY 06, 2021
Drug Discovery & Development
Are Hallucinations Necessary for Psychedelics to Treat Depression?
MAY 06, 2021
Are Hallucinations Necessary for Psychedelics to Treat Depression?
Many who work with psychedelics say that hallucinations, or psychedelic experiences, are an integral part of psychedelic ...
Loading Comments...